Every time I walk out of my apartment and walk past the mountain of packages left for residents in my building, I’m reminded of Amazon.com Inc. (NASDAQ: AMZN).
By now, everyone in the United States has heard of it. You see its packages and boxes in the recycling and delivery trucks with the large, unmistakable Amazon logo. It even has its own fleet of planes that you might see at the airport. Not just an e-commerce company, it also has a music service, the top video game streaming service, payments platform, an over-the-top entertainment platform, and one of the largest web services in the United States. This is how you create a trillion-dollar company.
According to Consumer Intelligence Research Partners, it has 112 million members in its Prime loyalty program as of December 2019. That is 34% of the U.S. population, and given that people sign up as families, eMarketer takes it one step further and suggests that 82% of households have a Prime account.
July 4 is one of my favorite holidays, and living in D.C., the excitement is intensified as a huge parade marches through the city and the night concludes at the National Mall with fireworks.
Living in Washington, D.C., it’s good to see that COVID-19 cases, which peaked on April 30, continue to decline. As a result, restaurants, retail stores, and some barbershops have started to open in a limited capacity.
But that reopening isn’t happening everywhere.
There are still thousands of new cases daily across the United States and many states that have started to open back up such as Texas, California, and Florida continue to see a rise in new COVID-19 cases.
In our twice-weekly chats, I often suggest investments that are part of large tech sectors.
For instance, the life sciences field defines huge. Just the prescription drug segment alone will be worth $1.2 trillion by 2024, according to data from Statista.
So, you might be wondering why I am focused on a medical area that will be worth just 0.1% of that figure over roughly the same time frame.
It’s a fair question. The answer is pretty basic. A high-octane leader
focused on specialty drugs can make a killing.
And the one I’m going to reveal to you today defines profit machine. It’s on pace to double per-share earnings in as little as a year.
I want to start today’s chat with a tech-investing challenge.
How many of you can claim you have a stock in your portfolio that is up nearly 230% in just 16 months?
As impressive as that return sounds, it actually understates the strength of the stock I have in mind. It’s a medical device leader that recently received approval for a Covid-19 test.
It’s up 120 in the past two months alone…
But this is no flash in the pan. Even before that breakthrough occurred, the stock was a bona fide market crusher
From roughly the beginning of 2019 through the correction that began on February 19, the stock was ahead of the S&P 500 by an amazing 278.5%.
The firm I have in mind is leading the medical device market as part of a trend toward remote patient monitory.
With the coronavirus still fresh on everyone’s minds, the investment thesis is only getting better.
Not even a brutal market selloff can keep Amazon.com Inc. (AMZN) down.
Here’s the thing. This is no ordinary bear market, one defined as a 20% drop from the previous high.
It’s the coronavirus panic that has most of the economy in a deep freeze.
As a result, physical retail stores are getting hammered. The U.S. Commerce Department says retail sales for March fell a seasonally adjusted 8.7%.
That’s the biggest one-month decline since the agency began keeping records back in 1992.
And while Amazon definitely faced some supply chain issues, the King of E-commerce came through when the nation needed the tech giant’s help the most. It delivered millions of packages to homebound families all across America.
With that performance under its belt, yesterday the firm’s stock hit a record high – a feat that few stocks can match.
The coronavirus crisis is an event like nothing we’ve seen before in our lifetimes. It’s put an unprecedented strain on our economy by forcing people to stay in their homes. The markets may be down, but many of the same high-tech innovations that drove the pre-virus economy to new heights are helping society stay connected now. That means working from home, shopping for necessities online, and keeping in touch with friends and family. In short, online infrastructure has gone from convenient to totally indispensable. This is a prime opportunity for any online innovator to rise to the occasion, and rise in value. And when this crisis passes, tech will be poised to lead the market again. Click here to watch.
When we spoke on Tuesday, I made a bold prediction: the Covid-19 outbreak, while serious, will not be as bad as the worst-case predictions would have it.
For one, much of the country is already on lock-down, cutting off the spread of the disease. That is buying us some valuable time as researchers race to find a cure or at least a good treatment option.
And I’m happy to report there have been some exciting developments in the search for treatments and vaccines against Covid-19
Last week, I noted that most vaccine research remains rooted in 1950s technology.
Despite mapping the entire human genome back in April 2004, drug firms and scientists still rely on slowly growing viruses inside chicken eggs to create a vaccine.
This takes a lot of time – and a lot of eggs.
But the Covid-19 pandemic has them racing to find a treatment using novel and fascinating science.
Millions of Americans found yesterday’s headlines about the coronavirus more than a little disturbing.
After all, the number of U.S. cases has climbed above 10,000. And while that sounds like a lot from the standpoint of raw numbers, I believe at a time like this, it’s important to keep this kind of news in context.
In fact, I’m going to go out on a limb here and predict that the total number of infected Americans will be much less than what Big Media would have you believe.
I realize that many folks are scared and frustrated because the $1.2 trillion life sciences sector has not yet released a vaccine.
With that in mind, I am starting the first of a two-part series on that very subject.
Today, I will walk you through why we still use 1950s technology in the search for a vaccine.
By now, everyone in the United States has heard of it. You see its packages and boxes in the recycling and delivery trucks with the large, unmistakable Amazon logo. It even has its own fleet of planes that you might see at the airport. Not just an e-commerce company, it also has a music service, the top video game streaming service, payments platform, an over-the-top entertainment platform, and one of the largest web services in the United States. This is how you create a trillion-dollar company.